In yesterday’s Federal Register, The Drug Enforcement Agency announced the addition of code 7350 to better classify “marihuana extract.”
The DEA reported that the addition of this code would allow the agency and DEA-registered entities to more accurately track quantities of marijuana extracts and aide in more granular agency reporting.
This code, 7350, will be defined as an “extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant.”
This release made it clear that Marijuana Extract will still hold the classification of a Schedule I drug.
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are:
heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote
While this announcement only seems to help with regulatory reporting, it is unknown why there was a need to segment this marijuana derivative.